LAVA Therapeutics NV - SHS (LVTX)

Historical Portfolio Holders from Q1 2021 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / SHS
Shares, excl. options Q2 2024
3.76M
Holdings value Q2 2024
$6.77M
Value change Q2 2024
-$68.2K
Grand Portfolio weight change Q2 2024
0%
Number of holders
18
Number of buys Q2 2024
8
Number of sells Q2 2024
-7
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 3.76M $6.77M -$68.2K $1.80 19
2024 Q1 3.76M $12.5M -$2.09M $3.33 22
2023 Q4 5.84M $9.22M +$207K $1.58 13
2023 Q3 5.72M $8.47M -$47.2K $1.49 14
2023 Q2 5.75M $11.7M -$1.82M $2.03 16
2023 Q1 6.74M $11.2M -$1.63M $1.66 18
2022 Q4 7.37M $25.8M -$426K $3.50 18
2022 Q3 7.45M $34.1M -$58.9K $4.57 12
2022 Q2 7.84M $22.8M -$450K $2.95 16
2022 Q1 8M $35.2M -$409K $4.40 16
2021 Q4 8.05M $44.3M -$914K $5.50 18
2021 Q3 8.22M $48.6M -$5.13M $5.92 17
2021 Q2 8.77M $95.5M -$5.97M $10.88 18
2021 Q1 9.22M $139M +$139M $15.19 24